Internal Medicine, Medical Oncology · Lexington, KY
NPI
1982047973
Since 2013
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
800 Rose St
Lexington, KY, 40536
Phone (859) 257-4488
Groups this clinician bills Medicare through
Medicare paid, 2024
$36K
346 services
Medicare patients, 2024
184
Average age 73
Drug cost, 2024
$13.1M
2,394 prescriptions
Company payments, 2025
$176
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Zin W Myint was code 99215 (office e&m - established), 170 times for 95 patients. In total Zin W Myint billed 346 services in 11 codes, and Medicare paid $36K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-11-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 170 | 95 | $110.17 | $19K |
| 99214 Office E&M - Established | Facility | 77 | 64 | $57.28 | $4,411 |
| 99205 Office E&M - New | Facility | 48 | 48 | $136.66 | $6,560 |
| 99223 Hospital E&M - Initial | Facility | 18 | 18 | $139.28 | $2,507 |
By year: 2022 $26K for 250 services; 2023 $47K for 521 services; 2024 $36K for 346 services.
Medicare prescription drug claims, 2024
In 2024, the drug Zin W Myint prescribed most often to Medicare patients was Orgovyx (Relugolix), with 358 prescriptions and refills. In total Zin W Myint wrote 2,394 Medicare prescriptions that cost $13.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Orgovyx Relugolix | 358 | 369 | 51 | $1.0M |
| Prednisone Generic | 295 | 327 | 47 | $847 |
| Abiraterone Acetate Generic | 260 | 262 | 30 | $815K |
| Xtandi Enzalutamide | 253 | 253 | 31 | $3.1M |
| Erleada Apalutamide | 184 | 185 | 21 | $2.5M |
| Cabometyx Cabozantinib S-Malate | 118 | 118 | 17 | $2.8M |
| Oxycodone Hcl Generic | 106 | 106 | 39 | $2,040 |
| Prochlorperazine Maleate Generic | 79 | 79 | 45 | $1,108 |
| Nubeqa Darolutamide | 73 | 73 | Under 11 | $872K |
| Eliquis Apixaban | 30 | 42 | Under 11 | $23K |
| Gabapentin Generic | 30 | 31 | 12 | $171 |
| Amlodipine Besylate Generic | 30 | 40 | Under 11 | $34.72 |
| Levothyroxine Sodium Generic | 28 | 59 | Under 11 | $245 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 27 | 27 | Under 11 | $345 |
| Zytiga Abiraterone Acetate | 24 | 24 | Under 11 | $245K |
Brand drugs: 1,161 claims; generic drugs: 1,233 claims; opioid claims: 164.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Zin W Myint $176 ($176 in general payments such as food, travel and fees) from 7 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $107.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.